Shopping Cart
- Remove All
Your shopping cart is currently empty
Vatinoxan hydrochloride is an antagonist of the peripheral α2 adrenergic receptors.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $5,970 | 8-10 weeks | |
| 50 mg | $9,540 | 8-10 weeks | |
| 100 mg | $13,400 | 8-10 weeks |
| Description | Vatinoxan hydrochloride is an antagonist of the peripheral α2 adrenergic receptors. |
| In vivo | When given simultaneously i.v Vatinoxan alone increases cardiac index and tissue oxygen delivery and has no deleterious adverse effects.In a dose-dependent manner Vatinoxan attenuates or prevents dexmedetomidine's systemic hemodynamic effects. A 50:1 dose ratio (Vatinoxan:dexmedetomidine) induces the least alterations in cardiovascular function[1]. Vatinoxan dose-dependently reduces bradycardia associated with dexmedetomidine and shortens the sedative effect without changing its quality. Vatinoxan may help reduce heart rate reduction in cats consciously administering dexmedetomidine[2]. |
| Synonyms | MK-467 hydrochloride, L-659066 hydrochloride |
| Molecular Weight | 454.97 |
| Formula | C20H27ClN4O4S |
| Cas No. | 130466-38-5 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: 133 mg/mL (292.33 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
H2O
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.